Momenta Files Patent Infringement Lawsuit against Mylan

shot by IP News Shots / 2:54 pm on 27 May, 2022

Momenta Pharmaceuticals Inc. filed a two-count patent infringement case in the U.S. District Court for the Western District of Pennsylvania targeting not only Mylan NV — which is now part of Viatris Inc. — but also Natco Pharma Ltd. and Gland Pharma Ltd. , which are companies based out of India. As per the lawsuit, Mylan has been imitating patented manufacturing methods to make a generic version of multiple sclerosis treatment.

Industry: Pharmaceuticals | Type of IP: Litigations

Read more at Law360